Title : Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours.

Pub. Date : 2003 Nov 17

PMID : 14612898






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours. vandetanib vascular endothelial growth factor A Mus musculus
2 Mice bearing PC-3 human prostate adenocarcinoma xenografts were treated with ZD6474, a VEGF receptor-2 (KDR) tyrosine kinase inhibitor. vandetanib vascular endothelial growth factor A Mus musculus